Benzinga | Aug 10, 2020 06:37AM EDT

Plus Therapeutics Q2 EPS $(0.45) Beats $(0.75) Estimate, Sales $185.00K Down From $302.00K YoY

Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.75) by 40 percent. This is a 91.21 percent increase over losses of $(5.12) per share from the same period last year. The company reported $185.00 thousand in sales this quarter. This is a 38.74 percent decrease over sales of $302.00 thousand the same period last year.